If acromegaly was not cured by surgery, therapy with the long-acting somatostatin analog, octreotide, was started. Immunohistochemical examinations of pituitary tumors included labeling for ...

The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly, said developer ...

Acromegaly is diagnosed with elevated IGF-1 and high GH levels that are not suppressed ... These include as somatostatin-receptor ligands (SRL) (lanreotide, octreotide), GH-receptor antagonists ...

Acromegaly Therapies and Key Companies . Paltusotine (CRN 00808): Crinetics Pharmaceuticals . CAM2029 (octreotide subcutaneous depot): Camurus AB Acromegaly Market Strengths . The development of ...